MiSeqDx

Compare MiSeqDx and MiSeq Systems
Compare MiSeqDx and MiSeq Systems

Each MiSeqDx system delivers comprehensive sequencing solutions to meet the unique needs of both healthcare providers and clinical researchers.


*Report generation is only available for the MiSeqDx Cystic Fibrosis 139-Variant Assay and the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay.

540 Mb–15 Gb

output range

12-25 million

reads per run

2 × 300 bp

max read length
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.
MiSeqDx Cystic Fibrosis 139-Variant Assay
MiSeqDx Cystic Fibrosis 139-Variant Assay

FDA-cleared NGS assay with the largest panel of clinically relevant, functionally validated cystic fibrosis variants in a diverse population.

MiSeqDx Cystic Fibrosis Clinical Sequencing Assay
MiSeqDx Cystic Fibrosis Clinical Sequencing Assay

FDA-cleared next-generation sequencing assay provides a full view of coding regions of the CFTR gene, to aid in in vitro diagnosis of cystic fibrosis.

MiSeqDx Universal Kit
MiSeqDx Universal Kit

A validated, FDA-cleared kit that enables molecular diagnostic laboratories to design their own next-generation sequencing assays for use on the MiSeqDx System.